Landos Biopharma, Inc. (LABP) Social Stream



Landos Biopharma, Inc. (LABP): $3.71

0.09 (-2.37%)

POWR Rating

Component Grades

Momentum

D

Stability

C

Sentiment

Quality

D

Add LABP to Watchlist
Sign Up

Industry: Biotech

Industry

NR

Ranked

#199 of 443

in industry

LANDOS BIOPHARMA INC (LABP) Price Targets From Analysts

The tables below show the price targets and recommendations analysts covering LABP.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-10-20 6 $50 $15 $32.833 $3.85 752.81%
2021-11-16 6 $50 $15 $30 $3.85 679.22%
2022-01-03 6 $50 $7 $28.666 $3.85 644.57%
2022-03-24 5 $50 $7 $26.166 $3.85 579.64%
2022-04-12 6 $50 $1.4 $21.4 $3.85 455.84%
2022-05-12 6 $50 $0.8 $24.16 $3.85 527.53%
2022-05-13 6 $50 $0.8 $18.2 $3.85 372.73%
2022-08-12 5 $50 $0.8 $17.933 $3.85 365.79%
2022-11-11 3 $2 $0.2 $1.1 $3.85 -71.43%
2023-02-08 3 $2 $0.1 $1.05 $3.85 -72.73%
2023-03-24 2 $2 $0.1 $1.05 $3.85 -72.73%
2023-05-12 1 $10 $10 $10 $3.85 159.74%
2023-05-16 2 $1 $0.1 $0.55 $3.85 -85.71%
2023-08-10 1 $5 $5 $5 $3.85 29.87%

Price Target Last Issued August 10, 2023

The Trend in the Analyst Price Target


LABP's average price target has moved down $23.33 over the prior 25 months.

Over the past 39 weeks, LABP's average upside potential has been 693.45%.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2023-02-08 3 2 0.1 1.05 0.385 172.73%
2023-05-12 2 10 10.0 10.00 0.298 3255.7%
2023-05-12 1 10 10.0 10.00 0.298 3255.7%
2023-05-16 2 1 0.1 0.55 0.290 89.66%
2023-05-16 2 1 0.1 0.55 2.905 -81.07%

LABP Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
3 0 0 1 0 0 1

The Trend in the Broker Recommendations


LABP's average broker recommendation rating worsened by 0.5 over the prior 52 weeks.

Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.

  • LANDOS BIOPHARMA INC's variance in analysts' estimates is lower than -1919.05% of all US stocks.
  • In the context of all US stocks, LANDOS BIOPHARMA INC's upside potential (average analyst target price relative to current price) is greater than 1399.13% of them.
  • LABP has a greater number of analysts covering the stock than 504.94% of Healthcare stocks.
  • LABP has a greater average analyst price target than 885.87% of stocks in the small market cap category.

In the Pharmaceutical Products industry, SNSE, PHVS, and CNTB are the three stocks most similar to LANDOS BIOPHARMA INC regarding the price target and analyst recommendation information presented here.

Is LABP a Buy, Hold or Sell? See the POWR Ratings now!


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!